February 15, 2022 — The American College of Cardiology’s Cardiovascular Summit Virtual (CV Summit) will feature three days of live content on Feb. 17-19, 2022, providing opportunities for the entire CV team to learn from multi-dimensional education courses on CV management and leadership strategies.

February 15, 2022 – A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA) outcomes when surgeon volume is greater than seven cases yearly and performed in hospitals with a 30-day mortality rate less than 5%.

“Open AAA repair has decreased in frequency owing to the increasing adoption of endovascular techniques, prompting concern that the decreased yearly clinical experience will affect operative results,” said senior author Adam Doyle, MD, from the University of Rochester Medical Center.

February 15, 2022 — Vaccine-associated myocarditis shows a similar injury pattern on cardiac MRI compared to other causes of myocarditis, but abnormalities are less severe, according to a new study published in the journal Radiology.

February 15, 2022 – Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University’s Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

February 15, 2022 — Viz.ai and TeleSpecialists, LLC  have entered a strategic partnership that will bring AI-powered stroke care together with leading telestroke neurologists to optimize time to treatment and improve patient outcomes across the United States.

February 15, 2022 — The leaders of three of the nation’s leading cardiology groups – American Heart Association President Donald M. Lloyd-Jones, M.D., Sc.M., FAHA; American College of Cardiology President Dipti Itchhaporia, MD, FACC and Association of Black Cardiologists Michelle A. Albert, MD, MPH – issued the following statement expressing support for the nomination of Robert M. Califf, M.D. as commissioner of the Food and Drug Administration (FDA) and urging a timely Senate confirmation vote:

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies, has announced the launch of EMBOGUARD, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

February 15, 2022 — UC Davis pediatric electrophysiologist

February 15, 2022 – The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) have announced the first-ever industry framework to evaluate and give guidance for consumer devices or applications designed to improve cardiovascular health. CTA and ACC have convened health and technology industry leaders to advance guidance and best practices for cardiovascular health technology developers and companies.

February 15, 2022 – Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) refinements and three new high-value tools. These updates come in the midst of American Heart Month and allow Cleerly technology to enter into the clinical workflows of health systems and providers across the U.S., drive new efficiencies, and deliver new insights to customers.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now